On 22.04., the first MEDIACC employees received their vaccination against SARS-CoV2. Thus, we can now pursue our valuable profession, namely to conduct clinical studies also for the containment of the current pandemic, with even more security. Currently, we have 3 active COVID-19 trials ongoing, and the number is increasing. We are prepared for the new challenges and look forward to contributing to many new innovations in the fight against COVID-19 and other diseases!